Dr. Armstrong Discusses Hereditary Prostate Cancer

Andrew J. Armstrong, MD
Published: Wednesday, Nov 01, 2017



Andrew J. Armstrong, MD, associate professor of medicine and surgery, Department of Medicine, Duke University School of Medicine, discusses the treatment of hereditary prostate cancer.

One of the most important findings of the past year was the identification of a form of hereditary prostate cancer, Armstrong says.

These mutations are called homologous repair enzymes, which create a very aggressive form of prostate cancer that effects 10% to 15% of men with metastatic prostate cancer.
 


Andrew J. Armstrong, MD, associate professor of medicine and surgery, Department of Medicine, Duke University School of Medicine, discusses the treatment of hereditary prostate cancer.

One of the most important findings of the past year was the identification of a form of hereditary prostate cancer, Armstrong says.

These mutations are called homologous repair enzymes, which create a very aggressive form of prostate cancer that effects 10% to 15% of men with metastatic prostate cancer.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 1st Annual International Congress of Oncology Pathology™: Towards Harmonization of Pathology and Oncology StandardsAug 30, 20182.0
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Publication Bottom Border
Border Publication
x